Annals of Microbiology and Research

Home / Browse Journals & Books / Annals of Microbiology and Research / Archive / Volume 5, Issue 1

Table of Content: Volume 5, Issue 1

Select All | |

Case Report Pages 137-139

Long Term Azithromycin use Reverses Post COVID-19 Lung Inflammation AND Fibrosis

Authors: M Khalid, Ihab Weheba, Abeer Abdelsayed, Sultan Alsayari and Eid Al Mutairy

Abstract: Corona Virus (COVID-19) disease has affected large number of people around the globe. Pandemic still not in control and it is still causing significant morbidity and mortality. One significant problem that is emerging post COVID-19 illness is the residual lung infiltrates/inflammation/fibrosis causing significant respiratory morbidity in these patients.

| | |

Research Article Pages 133-136

COVID-19, Vaccination and Healthy Living: Protecting Yourself or Exposing Others? The Kiss that Kills

Authors: Anne-Frédérique Naviaux, Pascal Janne and Maximilien Gourdin

Abstract: At a time when vaccines are spreading, there are still pockets of resistance, mainly of a social, psychological and behavioral nature, but also of an economic and health nature in developing countries. We focus here on the social, psychological and behavioral aspects of this resistance. The struggle against Covid-19 is becoming less and less immunological and more and more intrapsychic and social.

| | |

Research Article Pages 126-132

Early Pfizer Covid-19 Vaccine Elicited Spike Antibody (total, IgG, IgM) Responses Compared to Chemiluminescent Neutralizing Antibodies

Authors: Chin Shern LAU, MBBS, Soon Kieng PHUA, BSC, Ya Li LIANG, MSC, May Lin Helen OH, MBBS and Tar-Choon AW, MBBS

Abstract: Ten days after first vaccination, 64.6% (n = 42) and 66.2% (n = 43) were S-Ab (total and IgG) positive; however, only 13.8% (n = 9) and 10.8% (n = 7) were IgM and N-Ab positive. Younger patients (< 50-years-old) had significantly higher S-Ab responses after the first vaccine dose (difference between age groups: total 1.12 BAU/mL, 95% CI 0-3.69, p = 0.02; IgG 11.4 BAU/mL, 95% CI 2.72-37.1, p = 0.01; IgM COI 0.24, 95% CI 0.05-0.52, p = 0.01).

| | |

Research Article Pages 120-124

A Retrospective Study of Uropathogenic ESBL-producing Enterobacteriaceae among Hospitalized Patients, Khartoum-Sudan

Authors: Omnia M Hamid and Magdi A Bayoumi

Abstract: Uropathogenic extended-spectrum beta-lactamases-producing Enterobacteriaceae (ESBL-PE) remains a global cause of urinary tract infections (UTIs) among hospitalized patients as these enzymes hydrolysing 3rd generation cephalosporin’s (3rd GC). Those bacteria may not respond to therapy and thus further limiting antimicrobial selections. This study aimed to detect uropathogenic Enterobacteriaceae producing ESBL genes and their antimicrobial resistance pattern.

| | |

Case Report Pages 114-118

Phase 3 for COVID-19 in Italy: From a Retrospective Analysis on Deaths among Doctors in Hospitals to the Return of Children at School

Authors: Giancarlo Ranalli, Fabio Divino, Marco Ranalli and Giancarlo Ripabelli

Abstract: The cause of Coronavirus disease 2019 (COVID-19) is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is sadly well known for the dramatic loss of life it has led to; this new disease was declared a pandemic by the WHO on March 11, 2020. After the People’s Republic of China, a large part of Northern Italy (the Lombardy and Veneto Regions) was the first area in Europe to be seriously affected by COVID-19

| | |

Publish with Scholars.Direct

Track your Manuscript Status

(Please write to editorialoffice@scholars.direct in case of any technical error)